tozorakimab

Advertisement

cGxPJobs Banner

AstraZeneca Reports Phase III Success for Tozorakimab in COPD

CAMBRIDGE, United Kingdom, April 20, 2026 AstraZeneca has reported positive results from its pivotal Phase III MIRANDA trial, demonstrating...

By cGxPwire Editor
April 21, 2026

Read More

Advertisement

cGxPJobs

Directory